{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T11:30:26Z","timestamp":1787398226227,"version":"build-2736575974"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T00:00:00Z","timestamp":1637452800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1007\/s00415-021-10902-1","type":"journal-article","created":{"date-parts":[[2021,11,21]],"date-time":"2021-11-21T18:02:51Z","timestamp":1637517771000},"page":"3086-3093","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["Causes of symptom dissatisfaction in patients with generalized myasthenia gravis"],"prefix":"10.1007","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4780-7739","authenticated-orcid":false,"given":"Linda Kahr","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Sofie","family":"Jakobsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karoline Lolk","family":"Revsbech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Vissing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,11,21]]},"reference":[{"issue":"26","key":"10902_CR1","doi-asserted-by":"publisher","first-page":"2570","DOI":"10.1056\/NEJMra1602678","volume":"375","author":"NE Gilhus","year":"2016","unstructured":"Gilhus NE (2016) Myasthenia Gravis. N Engl J Med 375(26):2570\u20132581","journal-title":"N Engl J Med"},{"issue":"1","key":"10902_CR2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1002\/mus.24697","volume":"53","author":"JS Hansen","year":"2016","unstructured":"Hansen JS, Danielsen DH, Somnier FE, Fr\u00f8slev T, Jakobsen J, Johnsen SP et al (2016) Mortality in myasthenia gravis: A nationwide population-based follow-up study in Denmark. Muscle Nerve 53(1):73\u201377","journal-title":"Muscle Nerve"},{"issue":"1","key":"10902_CR3","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1097\/ALN.0000000000001159","volume":"125","author":"DN Wijeysundera","year":"2016","unstructured":"Wijeysundera DN, Johnson SR (2016) How much better is good enough?: Patient-reported outcomes, minimal clinically important differences, and patient acceptable symptom states in perioperative research. Anesthesiology 125(1):7\u201310","journal-title":"Anesthesiology"},{"key":"10902_CR4","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000010574","author":"M Mendoza","year":"2020","unstructured":"Mendoza M, Tran C, Bril V, Katzberg HD, Barnett C (2020) Patient-acceptable symptom states in myasthenia gravis. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000010574","journal-title":"Neurology"},{"issue":"11","key":"10902_CR5","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1111\/ene.14397","volume":"27","author":"D Menon","year":"2020","unstructured":"Menon D, Barnett C, Bril V (2020) Comparison of the single simple question and the patient acceptable symptom state in myasthenia gravis. Eur J Neurol 27(11):2286\u20132291","journal-title":"Eur J Neurol"},{"issue":"12","key":"10902_CR6","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1056\/NEJM198703193161205","volume":"316","author":"RS Tindall","year":"1987","unstructured":"Tindall RS, Rollins JA, Phillips JT, Greenlee RG, Wells L, Belendiuk G (1987) Preliminary results of a double-blind, randomized, placebo-controlled trial of cyclosporine in myasthenia gravis. N Engl J Med 316(12):719\u2013724","journal-title":"N Engl J Med"},{"issue":"6","key":"10902_CR7","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1002\/mus.21185","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB (2008) Muscle study. Group construction of an efficient evaluative instrument for myasthenia gravis: the MG composite. Muscle Nerve 38(6):1553\u20131562","journal-title":"Muscle Nerve"},{"issue":"7","key":"10902_CR8","doi-asserted-by":"publisher","first-page":"1487","DOI":"10.1212\/WNL.52.7.1487","volume":"52","author":"GI Wolfe","year":"1999","unstructured":"Wolfe GI, Herbelin L, Nations SP, Foster B, Bryan WW, Barohn RJ (1999) Myasthenia gravis activities of daily living profile. Neurology 52(7):1487\u20131489","journal-title":"Neurology"},{"issue":"7","key":"10902_CR9","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s00415-020-09770-y","volume":"267","author":"J Vissing","year":"2020","unstructured":"Vissing J, Jacob S, Fujita KP, O\u2019Brien F, Howard JF (2020) REGAIN study group \u201cMinimal symptom expression\u201d in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab. J Neurol 267(7):1991","journal-title":"J Neurol"},{"issue":"2","key":"10902_CR10","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1002\/mus.21053","volume":"38","author":"TM Burns","year":"2008","unstructured":"Burns TM, Conaway MR, Cutter GR, Sanders DB (2008) Muscle study. Group Less is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gravis. Muscle Nerve 38(2):957\u2013963","journal-title":"Muscle Nerve"},{"issue":"3","key":"10902_CR11","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/0022-3999(94)00125-O","volume":"39","author":"EM Smets","year":"1995","unstructured":"Smets EM, Garssen B, Bonke B, De Haes JC (1995) The Multidimensional Fatigue Inventory (MFI) psychometric qualities of an instrument to assess fatigue. J Psychosom Res 39(3):315\u2013325","journal-title":"J Psychosom Res"},{"issue":"6","key":"10902_CR12","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1080\/13548506.2015.1032310","volume":"20","author":"P Mikula","year":"2015","unstructured":"Mikula P, Nagyova I, Krokavcova M, Vitkova M, Rosenberger J, Szilasiova J et al (2015) The mediating effect of coping on the association between fatigue and quality of life in patients with multiple sclerosis. Psychol Health Med 20(6):653\u2013661","journal-title":"Psychol Health Med"},{"issue":"1","key":"10902_CR13","doi-asserted-by":"publisher","first-page":"9660","DOI":"10.1038\/s41598-019-46149-0","volume":"9","author":"MM Visser","year":"2019","unstructured":"Visser MM, Goodin P, Parsons MW, Lillicrap T, Spratt NJ, Levi CR et al (2019) Modafinil treatment modulates functional connectivity in stroke survivors with severe fatigue. Sci Rep 9(1):9660","journal-title":"Sci Rep"},{"issue":"5","key":"10902_CR14","doi-asserted-by":"publisher","first-page":"702","DOI":"10.5535\/arm.2018.42.5.702","volume":"42","author":"J Lexell","year":"2018","unstructured":"Lexell J, Jonasson SB, Brogardh C (2018) Psychometric properties of three fatigue rating scales in individuals with late effects of polio. Ann Rehabil Med 42(5):702\u2013712","journal-title":"Ann Rehabil Med"},{"issue":"2\u20133","key":"10902_CR15","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/S0165-0327(00)00309-8","volume":"66","author":"P Bech","year":"2001","unstructured":"Bech P, Rasmussen NA, Olsen LR, Noerholm V, Abildgaard W (2001) The sensitivity and specificity of the major depression inventory, using the present state examination as the index of diagnostic validity. J Affect Disord 66(2\u20133):159\u2013164","journal-title":"J Affect Disord"},{"issue":"2","key":"10902_CR16","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1017\/S0033291702006724","volume":"33","author":"LR Olsen","year":"2003","unstructured":"Olsen LR, Jensen DV, Noerholm V, Martiny K, Bech P (2003) The internal and external validity of the major depression inventory in measuring severity of depressive states. Psychol Med 33(2):351\u2013356","journal-title":"Psychol Med"},{"issue":"4","key":"10902_CR17","doi-asserted-by":"publisher","first-page":"700","DOI":"10.1002\/mus.25552","volume":"56","author":"MA Rahbek","year":"2017","unstructured":"Rahbek MA, Mikkelsen EE, Overgaard K, Vinge L, Andersen H, Dalgas U (2017) Exercise in myasthenia gravis: A feasibility study of aerobic and resistance training. Muscle Nerve 56(4):700\u2013709","journal-title":"Muscle Nerve"},{"issue":"9","key":"10902_CR18","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1002\/1097-4598(200009)23:9<1402::AID-MUS11>3.0.CO;2-B","volume":"23","author":"RH Paul","year":"2000","unstructured":"Paul RH, Cohen RA, Goldstein JM, Gilchrist JM (2000) Fatigue and its impact on patients with myasthenia gravis. Muscle Nerve 23(9):1402\u20131406","journal-title":"Muscle Nerve"},{"issue":"5","key":"10902_CR19","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/0021-9681(87)90171-8","volume":"40","author":"ME Charlson","year":"1987","unstructured":"Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40(5):373\u2013383","journal-title":"J Chronic Dis"},{"issue":"2","key":"10902_CR20","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1213\/ANE.0000000000004239","volume":"130","author":"H Mouri","year":"2020","unstructured":"Mouri H, Jo T, Matsui H, Fushimi K, Yasunaga H (2020) Effect of sugammadex on postoperative myasthenic crisis in myasthenia gravis patients: propensity score analysis of a japanese nationwide database. Anesth Analg 130(2):367\u2013373","journal-title":"Anesth Analg"},{"key":"10902_CR21","unstructured":"EQ-5D [Internet]. [cited 2020 Sep 28]. Available from: https:\/\/euroqol.org\/"},{"issue":"5","key":"10902_CR22","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1177\/1403494809105287","volume":"37","author":"KU Wittrup-Jensen","year":"2009","unstructured":"Wittrup-Jensen KU, Lauridsen J, Gudex C, Pedersen KM (2009) Generation of a danish TTO value set for EQ-5D health states. Scand J Public Health 37(5):459\u2013466","journal-title":"Scand J Public Health"},{"issue":"6","key":"10902_CR23","doi-asserted-by":"publisher","first-page":"1802","DOI":"10.1007\/s00415-020-09767-7","volume":"267","author":"YV Gavrilov","year":"2020","unstructured":"Gavrilov YV, Alekseeva TM, Kreis OA, Valko PO, Weber KP, Valko Y (2020) Depression in myasthenia gravis: a heterogeneous and intriguing entity. J Neurol 267(6):1802\u20131811","journal-title":"J Neurol"},{"issue":"10","key":"10902_CR24","doi-asserted-by":"publisher","first-page":"2312","DOI":"10.1007\/s00415-018-8995-4","volume":"265","author":"TM Alekseeva","year":"2018","unstructured":"Alekseeva TM, Gavrilov YV, Kreis OA, Valko PO, Weber KP, Valko Y (2018) Fatigue in patients with myasthenia gravis. J Neurol 265(10):2312\u20132321","journal-title":"J Neurol"},{"issue":"10","key":"10902_CR25","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.538","volume":"6","author":"S Hoffmann","year":"2016","unstructured":"Hoffmann S, Ramm J, Grittner U, Kohler S, Siedler J, Meisel A (2016) Fatigue in myasthenia gravis: risk factors and impact on quality of life. Brain Behav 6(10):e00538","journal-title":"Brain Behav"},{"issue":"2","key":"10902_CR26","first-page":"87","volume":"35","author":"W Kittiwatanapaisan","year":"2003","unstructured":"Kittiwatanapaisan W, Gauthier DK, Williams AM, Oh SJ (2003) Fatigue in myasthenia gravis patients. J Neurosci Nurs J Am Assoc Neurosci Nurs 35(2):87\u201393","journal-title":"J Neurosci Nurs J Am Assoc Neurosci Nurs"},{"issue":"12","key":"10902_CR27","doi-asserted-by":"publisher","first-page":"2136","DOI":"10.1093\/rheumatology\/ket169","volume":"52","author":"F Matcham","year":"2013","unstructured":"Matcham F, Rayner L, Steer S, Hotopf M (2013) The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysis. Rheumatol Oxf Engl 52(12):2136\u20132148","journal-title":"Rheumatol Oxf Engl"},{"key":"10902_CR28","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.jns.2016.11.067","volume":"372","author":"RE Boeschoten","year":"2017","unstructured":"Boeschoten RE, Braamse AMJ, Beekman ATF, Cuijpers P, van Oppen P, Dekker J et al (2017) Prevalence of depression and anxiety in multiple sclerosis: A systematic review and meta-analysis. J Neurol Sci 372:331\u2013341","journal-title":"J Neurol Sci"},{"key":"10902_CR29","doi-asserted-by":"publisher","DOI":"10.1136\/bmjdrc-2019-001071","author":"B Carstensen","year":"2020","unstructured":"Carstensen B, R\u00f8nn PF, J\u00f8rgensen ME (2020) Prevalence, incidence and mortality of type 1 and type 2 diabetes in Denmark 1996\u20132016. BMJ Open Diabetes Res Care. https:\/\/doi.org\/10.1136\/bmjdrc-2019-001071","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"24","key":"10902_CR30","first-page":"1998","volume":"171","author":"H Ibsen","year":"2009","unstructured":"Ibsen H, J\u00f8rgensen T, Jensen GB, Jacobsen IA (2009) Hypertension\u2013prevalence and treatment. Ugeskr Laeger 171(24):1998\u20132000","journal-title":"Ugeskr Laeger"},{"issue":"6","key":"10902_CR31","doi-asserted-by":"publisher","first-page":"707","DOI":"10.1002\/mus.26695","volume":"60","author":"G Cutter","year":"2019","unstructured":"Cutter G, Xin H, Aban I, Burns TM, Allman PH, Farzaneh-Far R et al (2019) Cross-sectional analysis of the myasthenia gravis patient registry: disability and treatment. Muscle Nerve 60(6):707\u2013715","journal-title":"Muscle Nerve"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-021-10902-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-021-10902-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,20]],"date-time":"2022-05-20T03:33:52Z","timestamp":1653017632000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-021-10902-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,21]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["10902"],"URL":"https:\/\/doi.org\/10.1007\/s00415-021-10902-1","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,11,21]]},"assertion":[{"value":"6 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 November 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 November 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 November 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Vissing received an unrestricted grant from Argenx to cover salary and patient transport expenses. The company had no influence on study design or in the writing of the manuscript. Andersen, Jakobsson, and Revsbech report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the ethics committee of the Capital Region of Denmark.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed consent was obtained from all included patients.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"N\/A.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}